Invectys, Inc. is a privately owned clinical-stage company, headquartered in Houston, Texas, which is developing a new generation of First-in-Class products for cancer patients. Invectys has two wholly owned subsidiaries, Invectys, SAS (Paris) which is focused on scientific research and innovation and Invectys USA, Inc. (Houston) which is directing the clinical development of the Company’s lead HLA-G product.
Since 2010, Invectys has raised over $60 million in private funds to develop its two innovative platforms of immunotherapy products which target “universal” tumor antigens.
Company Details
- Employees
- 19
- Founded
- -
- Address
- 12, Rue Jean-Antoine De Baïf, Paris,île-De-France 75013,france
- Phone
- 585-278-3001
- Industry
- Biotechnology
- Website
- invectys.com
- Keywords
- oncology, immunotherapy, biotech.
- HQ
- Paris, Île-de-France
Invectys Questions
Invectys's helpline number is 585-278-3001
Invectys's website is invectys.com
Invectys's LinkedIn profile is https://fr.linkedin.com/company/invectys
Invectys has
19 employees.
View email and phone details for 19
employees at Invectys.
Invectys's industry is
Biotechnology
Invectys's top competitors are
Oncovita,
Stimunity,
Abivax,
Enterome,
Acticor Biotech,
Biomunex Pharmaceuticals,
Theravectys,
Pep-Therapy,
Ose Immunotherapeutics,
Cellectis.
Invectys's categories are Biotechnology
Invectys's founding year is 2010
